"Fundación ACE es una entidad sin ánimo de lucro al servicio de las personas con enfermedad de Alzheimer u otras demencias, y de sus familias. Para hacerlo trabajamos desde 1996 en los campos del diagnóstico, tratamiento, investigación, formación y sensibilización."

During the past decade, Fundacion ACE conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundacion ACE" are "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Fundacion ACE" in a lesser frequency.

Most popular intervention types in "Fundacion ACE" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atabecestat" (1 trials), "Placebo" (1 trials), "REM0046127 High Dose" (1 trials) and "REM0046127 Low Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion ACE" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion ACE". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fundacion ACE, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion ACE, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".